Head-to-head for women
Eden vs REMEVi
Eden and REMEVi both offer GLP-1 telehealth to women, but they make different trade-offs on PCOS and hormonal suitability, clinical oversight, price and access. Here they are side-by-side on the Luna Fit Score — our women's-health rubric.
Eden
Higher scoreRanked #13 for women · Grade B+
Luna Fit
Best for: Women who value knowing exactly who is prescribing and where the medication comes from, and will pay above the cheapest tiers for that transparency.
FDA warning letterJune 2026Read it ↗Visit EdenREMEVi
Ranked #31 for women · Grade B
Luna Fit
Best for: Women who prioritize LegitScript accreditation and nationwide access, and don't mind mid-to-higher pricing.
Visit REMEViThe verdict for women
Eden edges out REMEVi on the Luna Fit Score, 88 to 85 (B+ vs B). Women who value knowing exactly who is prescribing and where the medication comes from, and will pay above the cheapest tiers for that transparency. The reasoning behind that number is in our Eden write-up for women.
REMEVi is still a genuine option — an accredited nationwide program with both molecules — solid oversight, though pricing sits toward the higher end. Weigh the six women's-health factors below against your own priorities; the REMEVi scorecard goes through each of them, and if neither of these two is the one, our ranked shortlist of REMEVi alternatives widens the field.
Side-by-side on the six factors
Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | Eden | REMEVi |
|---|---|---|
| Luna Fit Score | 88/100 · B+ | 85/100 · B |
| Overall rank | #13 | #31 |
| Semaglutide | $239/mo | $199/mo |
| Tirzepatide | $349/mo | $269/mo |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Luna Fit
Eden
Ranked #13 · Grade B+
What we like
- Clear clinician and supply-chain disclosure — among the most transparent in the ranking about who and what is behind the prescription
- Nationwide availability with both molecules
- High verification confidence: the facts it publishes hold up when checked
The caveats
- Premium pricing versus the cheapest tiers
- Compounded only — no brand-name access
- Not a hormone-specialty clinic; PCOS framing is general
Luna Fit
REMEVi
Ranked #31 · Grade B
What we like
- LegitScript-accredited and available in all 50 states
- Both molecules disclosed, tirzepatide for insulin-resistant PCOS
- Clear, predictable pricing
The caveats
- Higher-end pricing — $199 semaglutide, $269 tirzepatide
- No oral or brand-name option; general program without hormone specialization
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. Pricing, states and verification reflect each provider's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Neither Eden nor REMEVi is only worth comparing with the other. Eden is also written up against Ondra Health, an exact tie on the Luna Fit Score — see the Eden–Ondra Health head-to-head. REMEVi is also written up against CoreAge Rx, 8 points apart — see the REMEVi–CoreAge Rx head-to-head.
- Eden vs CoreAge Rx
- Eden vs Enhance MD
- Eden vs yourEra
- REMEVi vs Sesame Care
- REMEVi vs HealthRX
- REMEVi vs MadeMed
Or browse the full comparison hub.